In a public statement, BLA spokesman Jeeyand Baloch stated that their fighters executed a remote-controlled IED attack in the ...

Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing, and commercializing potentially best-in-class medicines for serious and rare diseases, today ...

Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, announced today that it has resubmitted the MOLBREEVI BLA to the FDA, with ...

Savara (SVRA) announced that it has resubmitted the Molbreevi BLA to the FDA, with Fujifilm as the drug substance manufacturer. The Molbreevi BLA ...

Pedro Rodriguez has been arrested for his alleged involvement in a home invasion at Tekashi 6ix9ine's Wellington residence, ...

Huonslab, a subsidiary of Huons Global (KOSDAQ:084110), has submitted a Biologics License Application (BLA) to the Ministry of Food and Drug Safety for its recombinant human hyaluronidase HYDIZYMEtm ...

Veligrotug, an IGF-1R inhibitor, is under FDA Priority Review for thyroid eye disease based on positive phase 3 trial data.

The FDA is expected to decide on treatments for breast cancer, EBV+ post-transplant lymphoproliferative disease, focal segmental glomerulosclerosis, presbyopia, and severe allergic reactions.

Discover why Mirum Pharmaceuticals, Inc. stock surged 65%. Explore robust pipeline growth, revenue outlook, and analyst ...

Brookdale Senior Living is proud to announce it has been recognized with two 2025 Aspect Marketing & Advertising Awards, earning top honors in both the Audio/Radio/Podcast Campaign (Provider) and ...

AstraZeneca's Andexxa will no longer be sold or manufactured in the US following FDA concerns around the drug's association ...